Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

Shares of AVGR opened at $0.47 on Wednesday. Avinger has a 1 year low of $0.36 and a 1 year high of $3.11. The stock has a 50 day simple moving average of $0.47 and a two-hundred day simple moving average of $0.60. The firm has a market cap of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.